Table 1 Characteristics of patients with pre-CCRT specimens.
Patient characteristic | Total (%) (N = 45) |
|---|---|
Age (years) | |
Mean (SD) | 63.9 (9.8) |
Sex | |
male | 36 (80) |
Smoking status | |
never-smoker | 6 (13) |
current or former smoker | 39 (87) |
Histology | |
adenocarcinoma | 19 (42) |
squamous | 24 (53) |
others | 2 (5) |
Stage | |
II A | 6 (13) |
II B | 8 (18) |
III A | 30 (67) |
III B | 1 (2) |
ECOG-PS | |
0 | 26 (58) |
1 | 19 (42) |
Chemo-radiotherapy regimen | |
Vinorelbine plus platinum | 30 (67) |
Docetaxel plus platinum | 10 (23) |
Paclitaxel plus platinum | 3 (6) |
S1 plus platinum | 1 (2) |
Pemetrexed plus platinum | 1 (2) |
Radiotherapy dose | |
40 Gy | 38 (84) |
50 Gy | 7 (16) |
Down staging * | |
Yes | 32 (71) |
No | 13 (29) |
PD-L1 status on tumor cells before CCRT | |
positive | 28 (62) |
negative | 17 (38) |
CD8+ lymphocytes density before CCRT** | |
high | 0 (0) |
intermediate | 14 (33) |
low | 29 (67) |
